Yokogawa Insilico Biotechnology Gmbh

Yokogawa Insilico Biotechnology Gmbh company information, Employees & Contact Information

Yokogawa Insilico Biotechnology GmbH delivers predictive Digital Twins for the biopharmaceutical industry. Insilico Digital Twins lead to superior productivity, product quality and process robustness by using artificial intelligence and mechanistic knowledge. As a result, Insilico's unique approach substantially reduces costs of manufacturing and time to market. Leading biopharmaceutical companies worldwide use Insilico Digital Twins for process development and manufacturing of drugs. Founded in 2001, Insilico Biotechnology is a privately held company based in Stuttgart, Germany.
Looking for a particular Yokogawa Insilico Biotechnology Gmbh employee's phone or email?

Yokogawa Insilico Biotechnology Gmbh Questions

News

Insilico Medicine provides benchmark timelines from its 22 AI-designed drug candidates - Fierce Biotech

Insilico Medicine provides benchmark timelines from its 22 AI-designed drug candidates Fierce Biotech

Biotech firm touts new AI drug discovery amid third Hong Kong IPO attempt - South China Morning Post

Biotech firm touts new AI drug discovery amid third Hong Kong IPO attempt South China Morning Post

Insilico Details AI-Designed IBD Candidate’s Path to Nomination - Genetic Engineering and Biotechnology News

Insilico Details AI-Designed IBD Candidate’s Path to Nomination Genetic Engineering and Biotechnology News

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production - - News-Medical

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production - News-Medical

Biotech startup Insilico CEO sees AI drugs may be ready by 2030 - Tech in Asia

Biotech startup Insilico CEO sees AI drugs may be ready by 2030 Tech in Asia

Bridging silicon and carbon worlds with digital twins and on-chip systems in drug discovery - Nature

Bridging silicon and carbon worlds with digital twins and on-chip systems in drug discovery Nature

Insilico Medicine named Top Biotech Company in Fast Company’s 2024 World’s Most Innovative Companies List - EurekAlert!

Insilico Medicine named Top Biotech Company in Fast Company’s 2024 World’s Most Innovative Companies List EurekAlert!

Yokogawa Acquires Insilico Biotechnology - Genetic Engineering and Biotechnology News

Yokogawa Acquires Insilico Biotechnology Genetic Engineering and Biotechnology News

New Paper from Insilico Medicine Demonstrates Validity of AI Drug Discovery - bio-itworld.com

New Paper from Insilico Medicine Demonstrates Validity of AI Drug Discovery bio-itworld.com

12 AI drug discovery companies you need to watch in 2025 - Labiotech.eu

12 AI drug discovery companies you need to watch in 2025 Labiotech.eu

Insilico Medicine Opens Largest AI-Powered Biotechnology Research Center in the Middle East - GlobeNewswire

Insilico Medicine Opens Largest AI-Powered Biotechnology Research Center in the Middle East GlobeNewswire

Paving the Way to Pharmaceutical Superintelligence: Insilico Medicine - Bioengineer.org

Paving the Way to Pharmaceutical Superintelligence: Insilico Medicine Bioengineer.org

Insilico 'pulls back the curtain' on AI drug discovery process in hope of convincing skeptics - Fierce Biotech

Insilico 'pulls back the curtain' on AI drug discovery process in hope of convincing skeptics Fierce Biotech

Insilico: linking target discovery and generative chemistry AI platforms for a drug discovery breakthrough - Nature

Insilico: linking target discovery and generative chemistry AI platforms for a drug discovery breakthrough Nature

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment - Genetic Engineering and Biotechnology News

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment Genetic Engineering and Biotechnology News

Amid 'biotech winter,' Insilico turns up the heat with Sanofi deal worth $1.2B in biobucks - Fierce Biotech

Amid 'biotech winter,' Insilico turns up the heat with Sanofi deal worth $1.2B in biobucks Fierce Biotech

Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience - EurekAlert!

Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience EurekAlert!

The Move toward Biopharma 4.0 - Genetic Engineering and Biotechnology News

The Move toward Biopharma 4.0 Genetic Engineering and Biotechnology News

Insilico Medicine and UAE University achieve collaboration to foster local talent and academic innovation - EurekAlert!

Insilico Medicine and UAE University achieve collaboration to foster local talent and academic innovation EurekAlert!

Insilico Medicine raises $110M for new trials and robotic helping hands - Fierce Biotech

Insilico Medicine raises $110M for new trials and robotic helping hands Fierce Biotech

Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors - Nature

Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors Nature

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models - Nature

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models Nature

Insilico Eyes Q4 Start for Late-Stage Trials of IPF Candidate - Genetic Engineering and Biotechnology News

Insilico Eyes Q4 Start for Late-Stage Trials of IPF Candidate Genetic Engineering and Biotechnology News

Insilico Medicine launches AI assistant for drafting medical research papers - Fierce Biotech

Insilico Medicine launches AI assistant for drafting medical research papers Fierce Biotech

Hong Kong-based biotech Insilico Medicine shifts IPO plan to city from New York - Yahoo Finance

Hong Kong-based biotech Insilico Medicine shifts IPO plan to city from New York Yahoo Finance

From target discovery to phase 1 initiation in under 30 months: AI-discovered and designed drug enters the clinic - Nature

From target discovery to phase 1 initiation in under 30 months: AI-discovered and designed drug enters the clinic Nature

Insilico's AI-designed med tied to respiratory health improvements in midstage lung disease trial - Fierce Biotech

Insilico's AI-designed med tied to respiratory health improvements in midstage lung disease trial Fierce Biotech

AIntibody: an experimentally validated in silico antibody discovery design challenge - Nature

AIntibody: an experimentally validated in silico antibody discovery design challenge Nature

Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission - Fierce Biotech

Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission Fierce Biotech

Computational Biology Market to Generate $9.52 Billion in - GlobeNewswire

Computational Biology Market to Generate $9.52 Billion in GlobeNewswire

Insilico Medicine licenses 2nd AI-generated cancer drug candidate to Menarini’s Stemline in $550M deal - Fierce Biotech

Insilico Medicine licenses 2nd AI-generated cancer drug candidate to Menarini’s Stemline in $550M deal Fierce Biotech

The most innovative companies in biotech in 2024 - Fast Company

The most innovative companies in biotech in 2024 Fast Company

Insilico raises $37M with plans to bring its AI to more drug discovery partnerships - Fierce Biotech

Insilico raises $37M with plans to bring its AI to more drug discovery partnerships Fierce Biotech

scDesign3 generates realistic in silico data for multimodal single-cell and spatial omics - Nature

scDesign3 generates realistic in silico data for multimodal single-cell and spatial omics Nature

Pfizer teams up with Insilico to mine data for drug targets - Fierce Biotech

Pfizer teams up with Insilico to mine data for drug targets Fierce Biotech

Menarini Group’s Stemline inks $500M+ biobucks deal for Insilico’s breast cancer candidate - Fierce Biotech

Menarini Group’s Stemline inks $500M+ biobucks deal for Insilico’s breast cancer candidate Fierce Biotech

(PDF) Exploring Medical Biotechnology - in vivo, in vitro, in silico: Biotechnology from Labs to Clinics and Basic to Advanced - researchgate.net

(PDF) Exploring Medical Biotechnology - in vivo, in vitro, in silico: Biotechnology from Labs to Clinics and Basic to Advanced researchgate.net

Insilico Medicine opens largest AI-powered biotech research centre in Middle East - BioSpectrum Asia

Insilico Medicine opens largest AI-powered biotech research centre in Middle East BioSpectrum Asia

Insilico Medicine's AI uncovers 28 new potential drug targets for ALS - Fierce Biotech

Insilico Medicine's AI uncovers 28 new potential drug targets for ALS Fierce Biotech

Insilico Medicine begins first human trial of its AI-designed drug for pulmonary fibrosis - Fierce Biotech

Insilico Medicine begins first human trial of its AI-designed drug for pulmonary fibrosis Fierce Biotech

Insilico signs $200M AI drug discovery partnership with China's CTFH - Fierce Biotech

Insilico signs $200M AI drug discovery partnership with China's CTFH Fierce Biotech

Insilico's weeks-old aging research spinout Deep Longevity picked up by Regent Pacific - Fierce Biotech

Insilico's weeks-old aging research spinout Deep Longevity picked up by Regent Pacific Fierce Biotech

Insilico Joins Scramble to Treat Solid Tumors by Targeting KIF18A - Genetic Engineering and Biotechnology News

Insilico Joins Scramble to Treat Solid Tumors by Targeting KIF18A Genetic Engineering and Biotechnology News

Insilico And Tenacia Collaborate To Advance CNS Therapeutics With Generative AI - Quantum Zeitgeist

Insilico And Tenacia Collaborate To Advance CNS Therapeutics With Generative AI Quantum Zeitgeist

Breaking Big Pharma's AI barrier: Insilico Medicine uncovers novel target, new drug for pulmonary fibrosis in 18 months - Fierce Biotech

Breaking Big Pharma's AI barrier: Insilico Medicine uncovers novel target, new drug for pulmonary fibrosis in 18 months Fierce Biotech

Sanofi signs with Hong Kong biotech firm Insilico to spur AI drug discovery - South China Morning Post

Sanofi signs with Hong Kong biotech firm Insilico to spur AI drug discovery South China Morning Post

Deep learning enables rapid identification of potent DDR1 kinase inhibitors - Nature

Deep learning enables rapid identification of potent DDR1 kinase inhibitors Nature

Australia drives digital transformation of biopharma sector with new ARC Hub - BioSpectrum Asia

Australia drives digital transformation of biopharma sector with new ARC Hub BioSpectrum Asia

Driving digital transformation of Australia’s biopharmaceutical sector with new ARC Hub - The University of Melbourne

Driving digital transformation of Australia’s biopharmaceutical sector with new ARC Hub The University of Melbourne

Global Digital Twin Market Industry Trends Report - GlobeNewswire

Global Digital Twin Market Industry Trends Report GlobeNewswire

Inside Insilico’s bid to create the UAE’s first homegrown cancer drug - Arabian Business

Inside Insilico’s bid to create the UAE’s first homegrown cancer drug Arabian Business

In Silico Pharmacology Modeling Market Is Going to Boom | Major Giants Certara, Schrodinger - newstrail.com

In Silico Pharmacology Modeling Market Is Going to Boom | Major Giants Certara, Schrodinger newstrail.com

Top Yokogawa Insilico Biotechnology Gmbh Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant